Results 21 to 30 of about 29,439 (214)
Microorganisms, 2020 Background: Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat in healthcare settings worldwide. Objectives: We evaluated the presence of carbapenemase genes in CPE in a tertiary care university hospital in Tokyo, Japan.
Satoshi Nishida +5 more
doaj +1 more source
Pathogens, 2023 (1) Background: Pseudomonas aeruginosa is a Gram-negative bacterium with several intrinsic and acquired antimicrobial resistance mechanisms. The spread of carbapenemase-encoding genes, an acquired mechanism, enables carbapenem resistance in clinical ...
María Guadalupe Martínez-Zavaleta +7 more
doaj +1 more source
Journal of Infection and Public Health, 2017 Summary: Little is known of carbapenemase producing Klebsiella pneumoniae (CPK) in Jordan. This study aimed to determine the prevalence of CPK in a major hospital in Amman, Jordan in 2012–2013 and to characterize the isolates and detect the types of ...
Amin A. Aqel +5 more
doaj +1 more source
Higher Rate of Extreme Drug-resistant Klebsiella pneumoniae Infections among Cardiac Patients
Journal of Nepal Health Research Council, 2022 Background: The accelerating rate of carbapenems resistance in Klebseilla pneumoniae isolates has put the treatment option worrisome. The effective strategy to ameliorate this alarming situation is possible through enhancing the combination therapy and ...
Subash Paudel +4 more
doaj +1 more source
Carbapenemase-producing Acinetobacter baumannii, Algeria [PDF]
European Journal of Clinical Microbiology & Infectious Diseases, 2010 EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, ISSN : 0934-9723, DOI : 10.1007/s10096-010-1011-2, Issue : 11, Volume : 29, pp. 1457-1458, November 2010.
DRISSI, M. +4 more
openaire +3 more sources
Frequency of Carbapenemase Producing Klebsiella pneumoniae in Makkah, Saudi Arabia
Journal of Microbiology and Infectious Diseases, 2016 Objective: Carbapenemase producing Klebsiella pneumoniae is emerging as an important pathogen worldwide which has alarming clinical threat with serious effects on patients ' outcome.
Mubashir Ahmad Khan, Aftab Faiz
doaj +1 more source
Annals of Clinical Microbiology and Antimicrobials, 2020 Background Antimicrobial resistance among nosocomial Gram-negative pathogens is a cause for concern in the Asia–Pacific region. The aims of this study were to measure the rates of resistance among clinical isolates collected in Asia–Pacific countries ...
Wen-Chien Ko, Gregory G. Stone
doaj +1 more source
The Immaculate Carbapenemase Study [PDF]
Journal of Clinical Microbiology, 2017 ABSTRACT Carbapenemase-producing organisms, or CPOs, are Gram-negative pathogens that produce a transmissible carbapenemase and are typically resistant to most (sometimes all) antibiotics. We now face a global CPO pandemic of high mortality. In this issue of the Journal of Clinical Microbiology , Karlowsky
openaire +2 more sources
Carbapenemase-Producing Organisms: A Global Scourge [PDF]
Clinical Infectious Diseases, 2017 The dramatic increase in the prevalence and clinical impact of infections caused by bacteria producing carbapenemases is a global health concern. Carbapenemase production is especially problematic when encountered in members of the family Enterobacteriaceae.
Bonomo, Robert A +6 more
openaire +3 more sources
Difference in Susceptibility Between Carbapenemase- and Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae [PDF]
Antimicrobial Stewardship & Healthcare Epidemiology, 2021 Background: Carbapenem-resistant Enterobacteriaceae (CRE) remain among the most urgent infectious threats according to the CDC Threats Reports. Although focus has often been placed on carbapenemase-producing phenotypes, there is increasing interest in distinguishing the optimal treatment and outcomes of carbapenemase-producing (CP) and non ...
Clark, Justin, Burgess, David
openaire +1 more source